Companhia de saneamento Basico Do Estado De Sao Paulo - Sabesp American Depositary Shares (Each repstg 250 Common Shares) vs TransMedics Group Inc — how do they compare? Companhia de saneamento Basico Do Estado De Sao Paulo - Sabesp American Depositary Shares (Each repstg 250 Common Shares) trades at $6.6 (market cap $23.36B), while TransMedics Group Inc trades at $79.01 (market cap $2.74B). The key difference: Companhia de saneamento Basico Do Estado De Sao Paulo - Sabesp American Depositary Shares (Each repstg 250 Common Shares) is far larger — about 8.5× TransMedics Group Inc's market cap, and Companhia de saneamento Basico Do Estado De Sao Paulo - Sabesp American Depositary Shares (Each repstg 250 Common Shares) pays a 0.51% dividend while TransMedics Group Inc pays none. Which is the better fit depends on your goals.
| SBS | TMDX | |
|---|---|---|
Market Cap | $23.36B | $2.74B |
Volume | 17,617,579 | 949,331 |
Sector | Utilities | Health |
52-Week High | $7.08 | $150.42 |
52-Week Low | $4.45 | $61.99 |
Enterprise Value | $30.17B | $3.13B |
Dividend Yield | 0.51% | — |
Typical Hold Time | — | 24 Days |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
TMDX trades at $81.07, up 0.98% today, but faces a bearish technical signal with recent price weakness. Fundamentally, the company reported strong 2025 results with $605.49M revenue and $190.29M net income, though 2026 projections show margin compression. Recent news highlights insider buying and ongoing legal investigations into fiduciary duties, creating mixed sentiment.
The stock offers potential upside to the $99.75 consensus target, supported by a 69% buy rating from analysts, but risks include earnings misses, margin pressure from heavy investment, and legal overhangs. Execution on growth amid rising costs remains critical for sustaining its premium valuation.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Sabesp provides water supply and sewage services in the Brazilian state of São Paulo. Its shares trade in Brazil as SBSP3 and in the U.S. as NYSE-listed ADSs under SBS.
Read more on SBS →TransMedics is a pioneering medical technology company that is disrupting the organ transplant market with its Organ Care System (OCS™). By replacing traditional cold storage with portable warm perfusion, the OCS maintains donor organs in a near-physiologic state, allowing for continuous assessment and optimization. Through its National OCS Program (NOP™), TransMedics provides an end-to-end clinical and logistics solution, including a dedicated aviation fleet, to maximize the utilization of donor organs and improve patient outcomes.
Read more on TMDX →